Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101

MYC Acts via the PTEN Tumor Suppressor to Elicit Autoregulation and Genome-Wide Gene Repression by Activation of the Ezh2 Methyltransferase

(2012) M. Kaur et al.   CANCER RESEARCH

Studies on Chemical Structure Modification and StructureActivity Relationship of Derivatives of Gambogic Acid at C(39)

(2012) Hao-Peng Sun et al.   CHEMISTRY & BIODIVERSITY

Studies on Chemical-Structure Modification and StructureActivity Relationship of Gambogic Acid Derivatives at Carbon(34)

(2012) Xiao-Jin Zhang et al.   CHEMISTRY & BIODIVERSITY

Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiation

(2012) Elad Milrot et al.   INVESTIGATIONAL NEW DRUGS

Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives

(2012) Tao Chen et al.   MOLECULES

Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity

(2011) Z Raviv et al.   BRITISH JOURNAL OF PHARMACOLOGY

AN N-terminal Smac peptide sensitizes human prostate carcinoma cells to methyl jasmonate-induced apoptosis

(2011) Guosong Jiang et al.   CANCER LETTERS

MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2

(2011) J. Lu et al.   CANCER RESEARCH

Deregulated expression of miR-26a and Ezh2 in Rhabdomyosarcoma

(2011) Roberta Ciarapica et al.   CELL CYCLE

Gambogic Acid, a Natural Product Inhibitor of Hsp90

(2011) Jason Davenport et al.   JOURNAL OF NATURAL PRODUCTS

Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder

(2011) Hang Wang et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Gambogic acid inhibits Hsp90 and deregulates TNF-α/NF-κB in HeLa cells

(2010) Lianru Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Gambogic acid triggers DNA damage signaling that induces p53/p21Waf1/CIP1 activation through the ATR-Chk1 pathway

(2010) Jing-Jing Rong et al.   CANCER LETTERS

Perillyl alcohol and methyl jasmonate sensitize cancer cells to cisplatin

(2009) Laxmi Yeruva et al.   ANTI-CANCER DRUGS

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1

(2009) M. Sachdeva et al.   CANCER RESEARCH

The Putative Tumor Suppressor microRNA-101 Modulates the Cancer Epigenome by Repressing the Polycomb Group Protein EZH2

(2009) J. M. Friedman et al.   CANCER RESEARCH

microRNA-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer Cells

(2009) P. Wang et al.   CANCER RESEARCH

Gambogic acid induces G0/G1 arrest and apoptosis involving inhibition of SRC-3 and inactivation of Akt pathway in K562 leukemia cells

(2009) Rui Li et al.   TOXICOLOGY

Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells

(2008) Tingting Wang et al.   CANCER LETTERS

Gambogic Acid Inhibits Angiogenesis and Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2 Signaling

(2008) T. Yi et al.   CANCER RESEARCH

Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins

(2008) Dayong Zhai et al.   MOLECULAR CANCER THERAPEUTICS

A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases

(2008) Roberta Benetti et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

(2008) Q Cao et al.   ONCOGENE

Proteomic identification of molecular targets of gambogic acid: Role of stathmin in hepatocellular carcinoma

(2008) Xin Wang et al.   PROTEOMICS